Single-Nucleotide Polymorphism-Defined Class I and Class III Major Histocompatibility Complex Genetic Subregions Contribute to Natural Long-term Nonprogression in HIV Infection

Archive ouverte

Guergnon, J. | Dalmasso, C. | Broet, P. | Meyer, L. | Westrop, S. J. | Imami, N. | Vicenzi, E. | Morsica, G. | Tinelli, M. | Poma, B. Zanone | Goujard, C. | Potard, V. | Gotch, F. M. | Casoli, C. | Cossarizza, A. | Macciardi, F. | Debré, P. | Delfraissy, J. F. | Galli, M. | Autran, B. | Costagliola, D. | Poli, G. | Theodorou, I. | Riva, A. | Consortium, G. I. S. H. E. A. L.

Edité par CCSD ; Oxford University Press -

International audience. We performed a genome-wide association study comparing a cohort of 144 human immunodeficiency virus (HIV type 1-infected, untreated white long-term nonprogressors (LTNPs) with a cohort of 605 HIV-1-infected white seroconverters. Forty-seven single-nucleotide polymorphisms (SNPs), located from class I to class III major histocompatibility complex (MHC) subregions, show statistical association (false discovery rate, <0.05) with the LTNP condition, among which 5 reached genome-wide significance after Bonferonni correction. The MHC LTNP-associated SNPs are ordered in >= 4 linkage disequilibrium blocks; interestingly, an MHC class III linkage disequilibrium block (defined by the rs9368699 SNP) seems specific to the LTNP phenotype.

Consulter en ligne

Suggestions

Du même auteur

Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established?

Archive ouverte | Goujard, C. | CCSD

International audience

Polymorphism in the proximal promoter region of the perforin gene and its impact on the course of HIV infection.

Archive ouverte | Mcilroy, Dorian | CCSD

International audience. Cytotoxic T lymphocytes (CTLs) play an essential role in the control of viral replication during human immunodeficiency virus (HIV) infection. However, the efficacy of the CTL response varies...

Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir

Archive ouverte | Bommenel, T. | CCSD

International audience. Objectives: To compare virological effectiveness in patients who continued on a virologically successful first-line boosted protease inhibitor (PI)-containing combination antiretroviral thera...

Chargement des enrichissements...